查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1968020

2026-2034年慢性静脉阻塞治疗全球市场规模、份额、趋势和成长分析报告

Global Chronic Venous Occlusions Treatment Market Size, Share, Trends & Growth Analysis Report 2026-2034
出版日期: | 出版商: Value Market Research | 英文 144 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

预计慢性静脉阻塞治疗市场规模将从 2025 年的 78.4 亿美元成长到 2034 年的 126.2 亿美元，2026 年至 2034 年的复合年增长率为 5.43%。

由于深层静脉栓塞症、血栓后症候群和其他静脉疾病的盛行率不断上升，全球慢性静脉阻塞治疗市场正经历稳定成长。人口老化和久坐的生活方式是造成全球慢性静脉阻塞负担的重要因素。微创血管内治疗技术的进步，包括导管导引溶栓和支架置入术，正在改善患者预后，并推动治疗方法在已开发经济体和新兴经济体的应用。

成长要素包括公众健康意识的提高、诊断影像技术的进步以及发展中地区医疗基础设施的扩张。随着患者越来越希望缩短住院时间、加速康復，对高效能微创治疗方法的需求也日益增长。此外，多个国家优惠的健保报销政策正在加速医院和专科诊所采用先进的静脉介入设备和治疗方法。

展望未来，药物释放型支架和影像引导介入系统等技术创新预计将对市场产生正面影响。临床研究的增加以及医疗设备製造商与医疗服务提供者之间合作的加强有望提高手术成功率。随着早期诊断的广泛应用和患者意识的提高，预计在整个预测期内市场将持续扩张。

目录

第一章：引言

第二章执行摘要

第三章 市场变数、趋势与框架

  • 市场谱系展望
  • 渗透率和成长前景分析
  • 价值链分析
  • 法律规范
    • 标准与合规性
    • 监管影响分析
  • 市场动态
    • 市场驱动因素
    • 市场限制因素
    • 市场机会
    • 市场挑战
  • 波特五力分析
  • PESTLE分析

第四章 全球慢性静脉阻塞治疗市场：依产品划分

  • 市场分析、洞察与预测
  • 装置
  • 製药

第五章 全球慢性静脉阻塞治疗市场：依应用领域划分

  • 市场分析、洞察与预测
  • 静脉曲张

第六章 全球慢性静脉阻塞治疗市场：依最终用途划分

  • 市场分析、洞察与预测
  • 医院
  • 门诊手术中心
  • 其他最终用户

第七章 全球慢性静脉阻塞治疗市场：依地区划分

  • 区域分析
  • 北美市场分析、洞察与预测
    • 我们
    • 加拿大
    • 墨西哥
  • 欧洲市场分析、洞察与预测
    • 英国
    • 法国
    • 德国
    • 义大利
    • 俄罗斯
    • 其他欧洲国家
  • 亚太市场分析、洞察与预测
    • 印度
    • 日本
    • 韩国
    • 澳洲
    • 东南亚
    • 其他亚太国家
  • 拉丁美洲市场分析、洞察与预测
    • 巴西
    • 阿根廷
    • 秘鲁
    • 智利
    • 其他拉丁美洲国家
  • 中东和非洲市场分析、洞察与预测
    • 沙乌地阿拉伯
    • UAE
    • 以色列
    • 南非
    • 其他中东和非洲国家

第八章 竞争情势

  • 最新趋势
  • 公司分类
  • 供应链和销售管道合作伙伴（根据现有资讯）
  • 市场占有率和市场定位分析（基于现有资讯）
  • 供应商情况（基于现有资讯）
  • 策略规划

第九章：公司简介

  • 主要公司的市占率分析
  • 公司简介
    • Bayer AG
    • Boston Scientific Corporation
    • Bristol Myers Squibb
    • Candela
    • ConvaTec Inc
    • Fotona
    • Julius Zorn GmbH
    • Leucadia Pharmaceuticals（Hikma）
    • Lumenis Ltd
    • Medi GmbH & Co. KG
    • Medtronic Plc
    • Merz Pharma
    • Pfizer Inc
    • Sanofi
简介目录
Product Code: VMR112110037

The Chronic Venous Occlusions Treatment Market size is expected to reach USD 12.62 Billion in 2034 from USD 7.84 Billion (2025) growing at a CAGR of 5.43% during 2026-2034.

The Global Chronic Venous Occlusions Treatment Market is experiencing steady growth due to the rising prevalence of deep vein thrombosis, post-thrombotic syndrome, and other venous disorders. Increasing aging populations and sedentary lifestyles have contributed significantly to the burden of chronic venous occlusions worldwide. Advancements in minimally invasive endovascular procedures, including catheter-directed thrombolysis and stent placement, are enhancing patient outcomes and expanding treatment adoption across developed and emerging economies.

Key growth drivers include growing awareness about venous health, improved diagnostic imaging technologies, and expanding healthcare infrastructure in developing regions. The demand for effective, less invasive treatment options is increasing as patients prefer shorter hospital stays and faster recovery times. Additionally, favorable reimbursement policies in several countries are encouraging hospitals and specialty clinics to adopt advanced venous intervention devices and therapies.

Looking ahead, the market is expected to benefit from technological innovations such as drug-eluting stents and image-guided intervention systems. Increasing clinical research and collaborations between medical device companies and healthcare providers will likely improve procedural success rates. As early diagnosis becomes more common and patient awareness rises, the market is projected to witness sustained expansion over the forecast period.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product

  • Devices
  • Drugs

By Application

  • Varicose veins

By End-use

  • Hospitals
  • Ambulatory Surgical Centers
  • Other End-Users

COMPANIES PROFILED

  • 3M Company, , Bayer AG, Boston Scientific Corporation, Bristol Myers Squibb, Candela, ConvaTec Inc, Fotona, Julius Zorn GmbH, Leucadia Pharmaceuticals Hikma, Lumenis Ltd, Medi GmbH Co KG, Medtronic plc, Merz Pharma, Pfizer Inc, Sanofi
  • We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1 Information Analysis
    • 1.3.2 Market Formulation & Data Visualization
    • 1.3.3 Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

  • 2.1. Market Snapshot
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Value Chain Analysis
  • 3.4. Regulatory Framework
    • 3.4.1 Standards & Compliance
    • 3.4.2 Regulatory Impact Analysis
  • 3.5. Market Dynamics
    • 3.5.1 Market Drivers
    • 3.5.2 Market Restraints
    • 3.5.3 Market Opportunities
    • 3.5.4 Market Challenges
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis

Chapter 4. GLOBAL CHRONIC VENOUS OCCLUSIONS TREATMENT MARKET: BY PRODUCT 2022-2034 (USD MN)

  • 4.1. Market Analysis, Insights and Forecast Product
  • 4.2. Devices Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.3. Drugs Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL CHRONIC VENOUS OCCLUSIONS TREATMENT MARKET: BY APPLICATION 2022-2034 (USD MN)

  • 5.1. Market Analysis, Insights and Forecast Application
  • 5.2. Varicose veins Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL CHRONIC VENOUS OCCLUSIONS TREATMENT MARKET: BY END-USE 2022-2034 (USD MN)

  • 6.1. Market Analysis, Insights and Forecast End-use
  • 6.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.3. Ambulatory Surgical Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.4. Other End-Users Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL CHRONIC VENOUS OCCLUSIONS TREATMENT MARKET: BY REGION 2022-2034(USD MN)

  • 7.1. Regional Outlook
  • 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.2.1 By Product
    • 7.2.2 By Application
    • 7.2.3 By End-use
    • 7.2.4 United States
    • 7.2.5 Canada
    • 7.2.6 Mexico
  • 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.3.1 By Product
    • 7.3.2 By Application
    • 7.3.3 By End-use
    • 7.3.4 United Kingdom
    • 7.3.5 France
    • 7.3.6 Germany
    • 7.3.7 Italy
    • 7.3.8 Russia
    • 7.3.9 Rest Of Europe
  • 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.4.1 By Product
    • 7.4.2 By Application
    • 7.4.3 By End-use
    • 7.4.4 India
    • 7.4.5 Japan
    • 7.4.6 South Korea
    • 7.4.7 Australia
    • 7.4.8 South East Asia
    • 7.4.9 Rest Of Asia Pacific
  • 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.5.1 By Product
    • 7.5.2 By Application
    • 7.5.3 By End-use
    • 7.5.4 Brazil
    • 7.5.5 Argentina
    • 7.5.6 Peru
    • 7.5.7 Chile
    • 7.5.8 South East Asia
    • 7.5.9 Rest of Latin America
  • 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.6.1 By Product
    • 7.6.2 By Application
    • 7.6.3 By End-use
    • 7.6.4 Saudi Arabia
    • 7.6.5 UAE
    • 7.6.6 Israel
    • 7.6.7 South Africa
    • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

  • 8.1. Recent Developments
  • 8.2. Company Categorization
  • 8.3. Supply Chain & Channel Partners (based on availability)
  • 8.4. Market Share & Positioning Analysis (based on availability)
  • 8.5. Vendor Landscape (based on availability)
  • 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL CHRONIC VENOUS OCCLUSIONS TREATMENT INDUSTRY

  • 9.1. Top Companies Market Share Analysis
  • 9.2. Company Profiles
    • 9.2.1 Bayer AG
    • 9.2.2 Boston Scientific Corporation
    • 9.2.3 Bristol Myers Squibb
    • 9.2.4 Candela
    • 9.2.5 ConvaTec Inc
    • 9.2.6 Fotona
    • 9.2.7 Julius Zorn GmbH
    • 9.2.8 Leucadia Pharmaceuticals (Hikma)
    • 9.2.9 Lumenis Ltd
    • 9.2.10 Medi GmbH & Co. KG
    • 9.2.11 Medtronic Plc
    • 9.2.12 Merz Pharma
    • 9.2.13 Pfizer Inc
    • 9.2.14 Sanofi